ARAP3 inhibits peritoneal dissemination of scirrhous gastric carcinoma cells by regulating cell adhesion and invasion

R. Yagi, M. Tanaka, K. Sasaki, R. Kamata, Y. Nakanishi, Yae Kanai, R. Sakai

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

During the analysis of phosphotyrosine-containing proteins in scirrhous gastric carcinoma cell lines, we observed an unusual expression of Arf-GAP with Rho-GAP domain, ankyrin repeat and PH domain 3 (ARAP3), a multimodular signaling protein that is a substrate of Src family kinases. Unlike other phosphotyrosine proteins, such as CUB domain-containing protein 1 (CDCP1) and Homo sapiens chromosome 9 open reading frame 10/oxidative stress-associated Src activator (C9orf10/Ossa), which are overexpressed and hyperphosphorylated in scirrhous gastric carcinoma cell lines, ARAP3 was underexpressed in cancerous human gastric tissues. In this study, we found that overexpression of ARAP3 in the scirrhous gastric carcinoma cell lines significantly reduced peritoneal dissemination. In vitro studies also showed that ARAP3 regulated cell attachment to the extracellular matrix, as well as invasive activities. These effects were suppressed by mutations in the Rho-GTPase-activating protein (GAP) domain or in the C-terminal two tyrosine residues that are phosphorylated by Src. Thus, the expression and phosphorylation state of ARAP3 may affect the invasiveness of cancer by modulating cell adhesion and motility. Our results suggest that ARAP3 is a unique Src substrate that suppresses peritoneal dissemination of scirrhous gastric carcinoma cells.

Original languageEnglish
Pages (from-to)1413-1421
Number of pages9
JournalOncogene
Volume30
Issue number12
DOIs
Publication statusPublished - 2011 Mar 24
Externally publishedYes

Fingerprint

Scirrhous Adenocarcinoma
Ankyrin Repeat
Cell Adhesion
Stomach
Phosphotyrosine
Cell Line
GTPase-Activating Proteins
Chromosomes, Human, Pair 9
Proteins
src-Family Kinases
Open Reading Frames
Cell Movement
Extracellular Matrix
Tyrosine
PH.3
Pleckstrin Homology Domains
Oxidative Stress
Phosphorylation
Mutation

Keywords

  • ARAP3
  • cell-ECM adhesion
  • invasion
  • Rho- GAP
  • scirrhous gastric carcinoma

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

ARAP3 inhibits peritoneal dissemination of scirrhous gastric carcinoma cells by regulating cell adhesion and invasion. / Yagi, R.; Tanaka, M.; Sasaki, K.; Kamata, R.; Nakanishi, Y.; Kanai, Yae; Sakai, R.

In: Oncogene, Vol. 30, No. 12, 24.03.2011, p. 1413-1421.

Research output: Contribution to journalArticle

Yagi, R. ; Tanaka, M. ; Sasaki, K. ; Kamata, R. ; Nakanishi, Y. ; Kanai, Yae ; Sakai, R. / ARAP3 inhibits peritoneal dissemination of scirrhous gastric carcinoma cells by regulating cell adhesion and invasion. In: Oncogene. 2011 ; Vol. 30, No. 12. pp. 1413-1421.
@article{6ef69dc50dfe414499bcef998081f714,
title = "ARAP3 inhibits peritoneal dissemination of scirrhous gastric carcinoma cells by regulating cell adhesion and invasion",
abstract = "During the analysis of phosphotyrosine-containing proteins in scirrhous gastric carcinoma cell lines, we observed an unusual expression of Arf-GAP with Rho-GAP domain, ankyrin repeat and PH domain 3 (ARAP3), a multimodular signaling protein that is a substrate of Src family kinases. Unlike other phosphotyrosine proteins, such as CUB domain-containing protein 1 (CDCP1) and Homo sapiens chromosome 9 open reading frame 10/oxidative stress-associated Src activator (C9orf10/Ossa), which are overexpressed and hyperphosphorylated in scirrhous gastric carcinoma cell lines, ARAP3 was underexpressed in cancerous human gastric tissues. In this study, we found that overexpression of ARAP3 in the scirrhous gastric carcinoma cell lines significantly reduced peritoneal dissemination. In vitro studies also showed that ARAP3 regulated cell attachment to the extracellular matrix, as well as invasive activities. These effects were suppressed by mutations in the Rho-GTPase-activating protein (GAP) domain or in the C-terminal two tyrosine residues that are phosphorylated by Src. Thus, the expression and phosphorylation state of ARAP3 may affect the invasiveness of cancer by modulating cell adhesion and motility. Our results suggest that ARAP3 is a unique Src substrate that suppresses peritoneal dissemination of scirrhous gastric carcinoma cells.",
keywords = "ARAP3, cell-ECM adhesion, invasion, Rho- GAP, scirrhous gastric carcinoma",
author = "R. Yagi and M. Tanaka and K. Sasaki and R. Kamata and Y. Nakanishi and Yae Kanai and R. Sakai",
year = "2011",
month = "3",
day = "24",
doi = "10.1038/onc.2010.522",
language = "English",
volume = "30",
pages = "1413--1421",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - ARAP3 inhibits peritoneal dissemination of scirrhous gastric carcinoma cells by regulating cell adhesion and invasion

AU - Yagi, R.

AU - Tanaka, M.

AU - Sasaki, K.

AU - Kamata, R.

AU - Nakanishi, Y.

AU - Kanai, Yae

AU - Sakai, R.

PY - 2011/3/24

Y1 - 2011/3/24

N2 - During the analysis of phosphotyrosine-containing proteins in scirrhous gastric carcinoma cell lines, we observed an unusual expression of Arf-GAP with Rho-GAP domain, ankyrin repeat and PH domain 3 (ARAP3), a multimodular signaling protein that is a substrate of Src family kinases. Unlike other phosphotyrosine proteins, such as CUB domain-containing protein 1 (CDCP1) and Homo sapiens chromosome 9 open reading frame 10/oxidative stress-associated Src activator (C9orf10/Ossa), which are overexpressed and hyperphosphorylated in scirrhous gastric carcinoma cell lines, ARAP3 was underexpressed in cancerous human gastric tissues. In this study, we found that overexpression of ARAP3 in the scirrhous gastric carcinoma cell lines significantly reduced peritoneal dissemination. In vitro studies also showed that ARAP3 regulated cell attachment to the extracellular matrix, as well as invasive activities. These effects were suppressed by mutations in the Rho-GTPase-activating protein (GAP) domain or in the C-terminal two tyrosine residues that are phosphorylated by Src. Thus, the expression and phosphorylation state of ARAP3 may affect the invasiveness of cancer by modulating cell adhesion and motility. Our results suggest that ARAP3 is a unique Src substrate that suppresses peritoneal dissemination of scirrhous gastric carcinoma cells.

AB - During the analysis of phosphotyrosine-containing proteins in scirrhous gastric carcinoma cell lines, we observed an unusual expression of Arf-GAP with Rho-GAP domain, ankyrin repeat and PH domain 3 (ARAP3), a multimodular signaling protein that is a substrate of Src family kinases. Unlike other phosphotyrosine proteins, such as CUB domain-containing protein 1 (CDCP1) and Homo sapiens chromosome 9 open reading frame 10/oxidative stress-associated Src activator (C9orf10/Ossa), which are overexpressed and hyperphosphorylated in scirrhous gastric carcinoma cell lines, ARAP3 was underexpressed in cancerous human gastric tissues. In this study, we found that overexpression of ARAP3 in the scirrhous gastric carcinoma cell lines significantly reduced peritoneal dissemination. In vitro studies also showed that ARAP3 regulated cell attachment to the extracellular matrix, as well as invasive activities. These effects were suppressed by mutations in the Rho-GTPase-activating protein (GAP) domain or in the C-terminal two tyrosine residues that are phosphorylated by Src. Thus, the expression and phosphorylation state of ARAP3 may affect the invasiveness of cancer by modulating cell adhesion and motility. Our results suggest that ARAP3 is a unique Src substrate that suppresses peritoneal dissemination of scirrhous gastric carcinoma cells.

KW - ARAP3

KW - cell-ECM adhesion

KW - invasion

KW - Rho- GAP

KW - scirrhous gastric carcinoma

UR - http://www.scopus.com/inward/record.url?scp=79953057231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953057231&partnerID=8YFLogxK

U2 - 10.1038/onc.2010.522

DO - 10.1038/onc.2010.522

M3 - Article

C2 - 21076469

AN - SCOPUS:79953057231

VL - 30

SP - 1413

EP - 1421

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 12

ER -